scholarly journals Acute exacerbation in chronic bird fancier's lung with pleuroparenchymal fibroelastosis

2020 ◽  
Vol 9 (1) ◽  
Author(s):  
Keishi Sugino ◽  
Hirotaka Ono ◽  
Natsumi Watanabe ◽  
Seiji Igarashi ◽  
Akira Hebisawa ◽  
...  

2004 ◽  
Vol 43 (9) ◽  
pp. 835-837 ◽  
Author(s):  
Naohiko INASE ◽  
Hiroyuki SAKASHITA ◽  
Yoshio OHTANI ◽  
Yoko SOGOU ◽  
Yuki SUMI ◽  
...  


2020 ◽  
Vol 59 (12) ◽  
pp. 1541-1547
Author(s):  
Chizuru Futatsuya ◽  
Hiroshi Minato ◽  
Yurie Okayama ◽  
Kazuyoshi Katayanagi ◽  
Hiroshi Kurumaya ◽  
...  


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Aiko Sekine ◽  
Kohei Seo ◽  
Satoshi Matsukura ◽  
Masaaki Sato ◽  
Aya Shinozaki-Ushiku ◽  
...  

Abstract Background Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare lung disease that manifests as parenchymal fibrosis of the upper lung lobe and pleura. There have been no reports of IPPFE complicating pregnancy. Here, we report a case of IPPFE that deteriorated rapidly during pregnancy. Case presentation A 29-year-old woman presented with dyspnea and dry cough at 19 weeks of gestation. IPPFE with acute exacerbation was suspected on chest computed tomography (CT). Despite steroid treatment, her condition progressed. A cesarean section was performed at 28 weeks of gestation. On postoperative day 26, she underwent living-donor lung transplantation. She was discharged a year after transplantation. Conclusion Our experience suggested that when pregnancy is complicated by PPFE, the disease may deteriorate rapidly. In this case, even though IPPFE with acute exacerbation was diagnosed during pregnancy, live birth was achieved, and the mother survived after lung transplantation. Lung transplantation should be considered in these patients because, once advanced, pulmonary lesions may be irreversible.





2019 ◽  
Vol 58 (9) ◽  
pp. 1321-1328 ◽  
Author(s):  
Atsushi Miyamoto ◽  
Hironori Uruga ◽  
Nasa Morokawa ◽  
Shuhei Moriguchi ◽  
Yui Takahashi ◽  
...  


JMS SKIMS ◽  
2010 ◽  
Vol 13 (1) ◽  
pp. 15-19
Author(s):  
Bashir Ahmed Shah ◽  
Muzafar Ahmed Naik ◽  
Sajjad Rajab ◽  
Syed Muddasar ◽  
Ghulam Nabi Dhobi ◽  
...  

Objective: To study the significance of serum magnesium levels during COPD exacerbation and stability.Materials & Methods: The patient population consisted of all patients of COPD admitted as acute exacerbation as defined by the Anthonisens criteria, from June 2006 to may 2008. Same patients one month post discharge presenting to the OPD for routine check up as stable COPD served as controls. Results: A total number of 77 patients of COPD presenting as acute exacerbation were included in the study. The incidence of Hypomagnesaemia was 33.8% at admission; 5% at discharge and 4% at one month of post discharge in COPD patients. The mean serum magnesium levels were significantly lower in cases than controls (1.88±0.67mg/ dl V/S 2.3±0.36mg/dl; p<0.0001). Also, hypomagnesemia was present in higher number of cases (22/77, 33.8%) compared to controls, 3/75, 4.0%; (p<0.0001). Patients of COPD with acute exacerbation and hypomagnesemia, had longer duration of symptoms and had advanced stage III of COPD (p<0.001); and had raised mean corpuscle volume (p<0.045) and longer hospital stay (p<0.008).  Conclusion: We conclude COPD exacerbation is associated with hypomagnesemia. The duration of symptoms of more than 8 days, advanced stage of COPD (stage III) and raised MCV were associated with hypomagnesemia. We recommend to monitor serum magnesium levels in COPD patients with acute exacerbation at the time of admission and during their stay in the hospital.J Med Sci.2010;13(1);15-19



Sign in / Sign up

Export Citation Format

Share Document